Dr. Douglas B Mogul, United States
Maralixibat-treated patients with Alagille syndrome demonstrate event-free survival in a natural history comparison with patients from the GALA database: Application of real-world evidence analytics

Julie K Drobish, United States
Outcomes in pediatric liver transplant recipients receiving bilateral continuous erector spinae plane blocks

Ms. Amber Hager, Canada
Skeletal muscle fibre types in children with end-stage liver disease and myopenia at time of transplantation

Dr. Matthew Goldstein, United States
Trends in sedation and analgesia in the postoperative liver transplant patient admitted to the pediatric intensive care unit - An analysis of data from the Pediatric Health Information System (PHIS) Database

Dr. Matthew Goldstein, United States
Survey of analgesia and sedation practices in the pediatric intensive care unit in postoperative pediatric liver transplant patients

Dr. Anna Gold, Canada
Long-term neurodevelopmental outcomes following liver transplantation for metabolic disease

Mrs. Jennifer Lau, United States
PAtient-centered Research in TransplaNT-Engaging families+Recipients (PARTNER)

Dr. Douglas B Mogul, United States
Maralixibat improves xanthomas and hypercholesterolemia in children with Alagille syndrome: An integrated analysis from two clinical trials

Dr. Matthew D Price, United States
Risk factors for 30-day hospital readmission following pediatric liver transplant, a retrospective analysis of the Society of Pediatric Liver Transplantation (SPLIT) database

Mrs. Lynn c Suresh, United States
Transplant core nurses: An adjunct to traditional multidisciplinary transplant discharge education

Ms. Bryanna Domenick, United States
Single center survey of prevalence of viruses in pediatric liver explants

Arielle Melen, United States
Frequency of portal vein complications and treatment interventions following pediatric liver transplantation: A single-center retrospective review

Stephanie Saaybi, United States
Treatment of rapid recurrence of severe steatosis with combined GLP-1 agonist and growth hormone therapy in a pediatric patient with hypopituitarism transplanted for NASH cirrhosis

Dr. Donna C Koo, United States
Effect of immigration status on pediatric liver transplantation

Dr. Rachel B Schenker, United States
Transgender and gender non-conforming liver transplant patients at Children’s Hospital Los Angeles

Patricia L Fredrick, United States
MELD/PELD exception writing: Streamlined documentation of liver disease complications in the liver transplant evaluation note

Dr. Guillermo A Costaguta, Canada
Increase of circulating IgA levels after pediatric liver transplantation

Dr. Simone Kortbeek, Canada
Determining the minimally clinically important difference for the Pediatric Liver Transplant Quality of Life (PeLTQL) questionnaire, a pilot cohort study

Naseem Ravanbakhsh, United States
Cutaneovisceral angiomatosis with thrombocytopenia associated liver cirrhosis, a rare indication for pediatric orthotopic liver transplantation

Dr. Guillermo A Costaguta, Canada
Lack of differences in safety and effectivity among three induction immunosuppression protocols during the first-year post-liver transplantation in pediatric patients: A multicenter study.

Dr. Natasha Dilwali, United States
Maralixibat, an ileal bile acid transporter inhibitor, delays the need for liver transplant in patients with Alagille syndrome: Real-world experience

Mr. Eric Pahl, United States
Prediction of offer acceptance and graft type selection in deceased donor pediatric liver transplantation

Dr. Mary Flanagan, Canada
Unveiling the concerns of our children: Exploring overlooked worries through PROMs

Vicky Ng, Canada
Frailty in pediatric liver disease is associated with an increased incidence of readmissions after pediatric liver transplantation

Dr. Guillermo A Costaguta, Canada
Immunologic tolerance after metachronous liver and bone marrow transplantation from different donors

Dr. Natasha Dilwali, United States
Experiences in recanalization of cavernous veins in cavernous transformation of the portal vein

Dr. Kathryn Czepiel, United States
A case of portopulmonary hypertension and porto-sinusoidal vascular disease

Dr. Harry Sutton, Canada
Phenotype and long- term outcome in recurrent pediatric acute liver failure secondary to NBAS, RINT1 and SCYL1 mutations: A review and individual participant data analysis

Deepak Vikraman, United States
Comparison of clinical outcomes of left lateral segment liver transplant following normothermic machine perfusion versus static cold storage: A single center analysis

Dr. Madelyn Cohen, United States
Rise in the incidence of acute cellular rejection post-COVID: A large single center experience

Dr. Guillermo A Costaguta, Canada
Reduced thyme functionality in paediatric patients after liver transplantation

Dr. Guillermo A Costaguta, Canada
Heart-Liver transplantation in a patient with hepatocellular carcinoma secondary to Fontan-associated liver disease

Dr. Alexis Gumm, United States
4-year outcome of a quality improvement project to improve vaccinations in the pediatric liver transplant population

Mrs. Leandra Bitterfeld, United States
Understanding the impact of pre-transplant social determinants of health disparities on graft and patient survival: A single-center retrospective review

Mrs. Sherrie Logan, Canada
Characteristics and processes for writing lay summaries of healthcare evidence: A co-created scoping review and consultation exercise

Naseem Ravanbakhsh, United States
Fontan-associated liver disease: The role of liver elastography assessments pre and post orthotopic heart transplant

Dr. Patil Kavarian, United States
Expanding the newborn screening for biliary atresia using direct bilirubin: An implementation science study

Dr. Maia Noeder, United States
Addressing barriers to psychology post-pediatric liver transplantation: A multidisciplinary clinic model

Minoti Haribhai, United States
A case of donor-derived syphilis seroconversion in a pediatric liver transplant recipient

Dr. Ashwin Rammohan, India
Living donor liver transplantation for pediatric hepatocellular carcinoma: The need for selection criteria or a different disease?

Dr. Anu K Vasu Jr., India
Outcomes of living donor liver transplantation for hepatoblastoma in children - A study from Indian subcontinent

Dr. Anu K Vasu Jr., India
Achieving 100 paediatric liver transplantation per year: A Single centre experience

Minoti Haribhai, United States
Characterizing the clinical manifestations of chronic liver disease in patients with post-Fontan physiology

Dr. Anu K Vasu Jr., India
Long-term outcomes of an algorithmic approach to the management of post-transplant lymphoproliferative disorder in pediatric liver transplantation

Dr. Léticia Khendek, United States
Predictive factors of persisting splenomegaly and thrombocytopenia after pediatric liver transplant